However, in our case, although the BRAF V600E mutation was identified in both the lung cancer and thyroid lesion, we can only tell that this mutation drives carcinogenesis rather than identify the primary cancer site because this mutation exists in various malignancies including thyroid cancer and NSCLCs. This evidence concerns the gene BRAF and thyroid gland carcinoma.